BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25224461)

  • 21. Comparison of right ventricular apex and right ventricular outflow tract septum pacing in the elderly with normal left ventricular ejection fraction: long-term follow-up.
    Zhang HX; Qian J; Hou FQ; Liu YN; Mao JH
    Kardiol Pol; 2012; 70(11):1130-9. PubMed ID: 23180520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of defibrillation efficacy using implantable cardioverter-defibrillator with single- or dual-coil defibrillation leads and active can.
    Lubiński A; Lewicka-Nowak E; Zienciuk A; Królak T; Kempa M; Pazdyga A; Raczak G; Swiatecka G
    Kardiol Pol; 2005 Sep; 63(3):234-41; discussion 242-3. PubMed ID: 16180177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Managed Ventricular pacing versus VVI 40 Pacing (MVP) Trial: clinical background, rationale, design, and implementation.
    Sweeney MO; Ellenbogen KA; Miller EH; Sherfesee L; Sheldon T; Whellan D
    J Cardiovasc Electrophysiol; 2006 Dec; 17(12):1295-8. PubMed ID: 17081208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of right ventricular lead location on response to cardiac resynchronization therapy in patients with end-stage heart failure.
    Haghjoo M; Bonakdar HR; Jorat MV; Fazelifar AF; Alizadeh A; Ojaghi-Haghjghi Z; Esmaielzadeh M; Sadr-Ameli MA
    Europace; 2009 Mar; 11(3):356-63. PubMed ID: 19136489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term right ventricular implantable cardioverter-defibrillator lead performance in arrhythmogenic right ventricular cardiomyopathy.
    Herman AR; Gardner M; Steinberg C; Yeung-Lai-Wah JA; Healey JS; Leong-Sit P; Krahn AD; Chakrabarti S
    Heart Rhythm; 2016 Oct; 13(10):1964-70. PubMed ID: 27321245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of induced LV dyssynchrony by right ventricular apical pacing on all-cause mortality and heart failure hospitalization rates at long-term follow-up.
    Auger D; Hoke U; Marsan NA; Tops LF; Leong DP; Bertini M; Schalij MJ; Bax JJ; Delgado V
    J Cardiovasc Electrophysiol; 2014 Jun; 25(6):631-7. PubMed ID: 24575777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Right ventricular outflow tract placement of defibrillation leads: five year experience.
    Giudici MC; Barold SS; Paul DL; Schrumpf PE; Van Why KJ; Orias DW
    Pacing Clin Electrophysiol; 2004 Apr; 27(4):443-6. PubMed ID: 15078395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implantable cardioverter defibrillator lead placement in the middle cardiac vein after tricuspid valve surgery.
    Lopez JA
    Europace; 2012 Jun; 14(6):853-8. PubMed ID: 22333241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL;
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Right ventricular pacing is an independent predictor for ventricular tachycardia/ventricular fibrillation occurrence and heart failure events in patients with an implantable cardioverter-defibrillator.
    Gardiwal A; Yu H; Oswald H; Luesebrink U; Ludwig A; Pichlmaier AM; Drexler H; Klein G
    Europace; 2008 Mar; 10(3):358-63. PubMed ID: 18308756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Right ventricular outflow tract pacing: practical and beneficial. A 9-year experience of 460 consecutive implants.
    Vlay SC
    Pacing Clin Electrophysiol; 2006 Oct; 29(10):1055-62. PubMed ID: 17038136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The implantable cardioverter-defibrillator: the Portuguese experience].
    Adragão P; Neves J; Sousa J; Fançoni J; da Silva N; Antunes E; Elvas L; Bernardo J
    Rev Port Cardiol; 1997 Apr; 16(4):367-74, 351-2. PubMed ID: 9254126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT).
    Ruwald AC; Schuger C; Moss AJ; Kutyifa V; Olshansky B; Greenberg H; Cannom DS; Estes NA; Ruwald MH; Huang DT; Klein H; McNitt S; Beck CA; Goldstein R; Brown MW; Kautzner J; Shoda M; Wilber D; Zareba W; Daubert JP
    Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):785-92. PubMed ID: 25136077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fragmentation of the paced QRS complex: a marker of antitachycardia pacing effectiveness among ICD patients.
    Jiménez-Candil J; Moríñigo JL; Hernández J; Martín A; Durán O; Carlos Rama J; Ledesma C; Sánchez PL
    J Cardiovasc Electrophysiol; 2014 Oct; 25(10):1100-8. PubMed ID: 24816219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence and predictors of clinically relevant cardiac perforation associated with systematic implantation of active-fixation pacing and defibrillation leads: a single-centre experience with over 3800 implanted leads.
    Cano Ó; Andrés A; Alonso P; Osca J; Sancho-Tello MJ; Olagüe J; Martínez-Dolz L
    Europace; 2017 Jan; 19(1):96-102. PubMed ID: 26847075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Basal exit site of clinical ventricular tachycardia is an independent predictor of antitachycardia pacing failure in implantable cardioverter-defibrillators recipients.
    Boulé S; Brigadeau F; Marquié C; Salleron J; Klug D; Kouakam C; Guédon-Moreau L; Duhamel A; Acheré C; Wissocque L; Lacroix D; Kacet S
    Pacing Clin Electrophysiol; 2012 Oct; 35(10):1209-16. PubMed ID: 22817404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between myocardial substrate, implantable cardioverter defibrillator shocks and mortality in MADIT-CRT.
    Sood N; Ruwald AC; Solomon S; Daubert JP; McNitt S; Polonsky B; Jons C; Clyne CA; Zareba W; Moss AJ
    Eur Heart J; 2014 Jan; 35(2):106-15. PubMed ID: 24179073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship between pacing site and induction or termination of sustained monomorphic ventricular tachycardia by antitachycardia pacing.
    Yee R; Birgersdotter-Green U; Belk P; Jackson T; Christensen J; Wathen MS
    Pacing Clin Electrophysiol; 2010 Jan; 33(1):27-32. PubMed ID: 19930109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prophylactic catheter ablation for induced monomorphic ventricular tachycardia in patients with implantable cardioverter defibrillators as primary prevention.
    Hayashi T; Fukamizu S; Hojo R; Komiyama K; Tanabe Y; Tejima T; Soejima K; Nishizaki M; Hiraoka M; Ako J; Momomura S; Sakurada H
    Europace; 2013 Oct; 15(10):1507-15. PubMed ID: 23603305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.